Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.73
-3.09%
Mkt Cap $302.03M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-13.0%
Consensus $1.50 vs current $1.73
NASDAQ·Healthcare·Biotechnology
$1.73
-3.09%
Mkt Cap $302.03M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-13.0%
Consensus $1.50 vs current $1.73